{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:50:17Z","timestamp":1783677017794,"version":"3.55.0"},"reference-count":21,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2023,2,28]]},"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1136\/thorax-2022-219778","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T17:23:39Z","timestamp":1679419419000},"page":"637-639","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Lung cancer screening in advanced chronic obstructive pulmonary disease: helpful or harmful?"],"prefix":"10.1136","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8880-6567","authenticated-orcid":false,"given":"Mamta","family":"Ruparel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,3,21]]},"reference":[{"key":"2024051320403541000_78.7.637.1","unstructured":"Wilson JMG , Jungner G . Geneva: World Health Organization; Principles and practice of screening for disease \/ J, . 1968 Available: www.who.int\/iris\/handle\/10665\/37650 [Accessed 25 Aug 2015]."},{"key":"2024051320403541000_78.7.637.2","unstructured":"The UK NSC recommendation on Lung Cancer Screening, Available: www.screening.nhs.uk\/lungcancer [Accessed 26 Feb 2015]."},{"key":"2024051320403541000_78.7.637.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1104699"},{"key":"2024051320403541000_78.7.637.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911793"},{"key":"2024051320403541000_78.7.637.5","doi-asserted-by":"crossref","unstructured":"Bonney A , Malouf R , Marchal C , et al . Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality. Cochrane Database Syst Rev 2022;2022. doi:10.1002\/14651858.CD013829.pub2","DOI":"10.1002\/14651858.CD013829.pub2"},{"key":"2024051320403541000_78.7.637.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1301851"},{"key":"2024051320403541000_78.7.637.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312547"},{"key":"2024051320403541000_78.7.637.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002277","article-title":"Risk prediction models for selection of lung cancer screening candidates: a retrospective validation study","volume":"14","author":"Ten Haaf","year":"2017","journal-title":"PLoS Med"},{"key":"2024051320403541000_78.7.637.9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001764","article-title":"Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts","volume":"11","author":"Tammem\u00e4gi","year":"2014","journal-title":"PLoS Med"},{"key":"2024051320403541000_78.7.637.10","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-211377"},{"key":"2024051320403541000_78.7.637.11","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-214703"},{"key":"2024051320403541000_78.7.637.12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.lungcan.2021.09.012","article-title":"Analysis of the baseline performance of five UK lung cancer screening programmes","volume":"161","author":"Balata","year":"2021","journal-title":"Lung Cancer"},{"key":"2024051320403541000_78.7.637.13","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1513\/AnnalsATS.201911-857OC","article-title":"Prevalence, symptom burden, and underdiagnosis of chronic obstructive pulmonary disease in a lung cancer screening cohort","volume":"17","author":"Ruparel","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"2024051320403541000_78.7.637.14","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-213584"},{"key":"2024051320403541000_78.7.637.15","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212812"},{"key":"2024051320403541000_78.7.637.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2018.08.006"},{"key":"2024051320403541000_78.7.637.17","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201805-0986ST"},{"key":"2024051320403541000_78.7.637.18","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219334"},{"key":"2024051320403541000_78.7.637.19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.413"},{"key":"2024051320403541000_78.7.637.20","unstructured":"The Global Initiative for Chronic Obstructive Lung Disease (GOLD) report on COPD, Available: https:\/\/goldcopd.org\/2023-gold-report-2\/ [Accessed 21 Nov 2022]."},{"key":"2024051320403541000_78.7.637.21","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.21037\/tlcr-22-63","article-title":"Lung function impairment in the German lung cancer screening intervention study (LUSI): prevalence, symptoms, and associations with lung cancer risk, tumor histology and all-cause mortality","volume":"11","author":"Kaaks","year":"2022","journal-title":"Transl Lung Cancer Res"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2022-219778","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T03:54:55Z","timestamp":1715658895000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2022-219778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,21]]},"references-count":21,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,6,15]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1136\/thorax-2022-219778"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2022-219778","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,21]]}}}